Even though carriers of a heterozygous germline NBN variant have been linked to cancer risk,20,22,23,40,41 malignancies of lymphatic origin, in particular B-ALL, were underrepresented in these studies.21 Therefore, evaluation of this patient group has been limited. The gene discussed is NBN; the disease is cancer.